assessing metabolic tumor volume as a prognostic marker before car-t therapy for dlbcl
Published 1 year ago • 85 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
2:23
prognostic value of alc following bcma car t-cell therapy in multiple myeloma
-
3:33
ic valve - large linear flat lesion - emr
-
0:59
bismuth-corlette classification system for cholangiocarcinoma
-
1:31
tech tuesday : hematology case book
-
7:45
case 224: manual of cto pci - just marker
-
7:59
case 133: manual of pci - svg perforation
-
5:35
case 166: manual of cto pci - star investment
-
0:59
checkmate 8hw: hrqol outcomes of nivolumab and ipilimumab in msi-h/dmmr mcrc
-
1:15
ide-cel car t-cell therapy for r/r myeloma in karmma-3
-
1:55
euro4c: cardiac care of calcified and complex patients - esc congress 2019
-
4:16
case 148: manual of cto pci - protected left main cto pci
-
9:45
case 145: manual of cto pci - left main cto
-
![[complex pci 2018] live case demonstration 3](https://i.ytimg.com/vi/NzqaGaImEm8/mqdefault.jpg)
1:53:39
[complex pci 2018] live case demonstration 3
-
2:32:02
car-t map n. 3 (sud italia)
-
3:54
ic valve flat lesion emr
-
1:47
how tumor derived vesicles affect metabolism
-
5:03
meta-analysis: anti-bcma car-t in r/r myeloma
-
0:55
what is this mass?
-
5:01
antonio colombo case 3 my best complex pci with deb
-
1:37
reducing repeat biopsies in inflammatory bowel disease, ibd with cellvizio